CVS Health Files 8-K Report

TL;DR

CVS Health filed an 8-K on 12/10/24, mostly procedural stuff, no major news.

AI Summary

On December 10, 2024, CVS Health Corporation filed an 8-K report. The filing primarily concerns other events and financial statements/exhibits, with no specific new material events detailed in the provided text. The report confirms the company's principal executive offices are located at One CVS Drive, Woonsocket, Rhode Island.

Why It Matters

This 8-K filing serves as a public record of CVS Health's corporate activities and financial reporting, ensuring transparency for investors and stakeholders.

Risk Assessment

Risk Level: low — The filing is a routine 8-K report and does not disclose any new material events or risks.

Key Numbers

• 001-01011 — SEC File Number (Identifies the company's filing with the SEC.)
• 05-0494040 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• CVS HEALTH Corp (company) — Registrant
• 0000064803 (company) — Central Index Key
• One CVS Drive, Woonsocket, Rhode Island 02895 (company) — Principal executive offices
• December 10, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 per share CVS New York Stock Exchan
• $2,250,000,000 — ration (the "Company"), issued and sold $2,250,000,000 aggregate principal amount of the Compa
• $750,000,000 — eries A Junior Subordinated Notes") and $750,000,000 aggregate principal amount of the Compa

Filing Documents

• d910925d8k.htm (8-K) — 31KB
• d910925dex41.htm (EX-4.1) — 314KB
• d910925dex42.htm (EX-4.2) — 123KB
• d910925dex43.htm (EX-4.3) — 121KB
• d910925dex51.htm (EX-5.1) — 13KB
• g910925g1210045612927.jpg (GRAPHIC) — 2KB
• g910925g1210053120963.jpg (GRAPHIC) — 1KB
• 0001193125-24-274362.txt ( ) — 860KB
• cvs-20241210.xsd (EX-101.SCH) — 3KB
• cvs-20241210_lab.xml (EX-101.LAB) — 17KB
• cvs-20241210_pre.xml (EX-101.PRE) — 11KB
• d910925d8k_htm.xml (XML) — 3KB

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits . The exhibits to this Current Report on Form 8-K are as follows: INDEX TO EXHIBITS Exhibit Description 4.1 Subordinated Indenture, dated as of May 25, 2007, between CVS Health Corporation (as successor to CVS Caremark Corporation) and The Bank of New York Mellon Trust Company, N.A. (as successor to The Bank of New York Trust Company, N.A.) 4.2 Second Supplemental Indenture, dated as of December 10, 2024, between CVS Health Corporation and The Bank of New York Mellon Trust Company, N.A. 4.3 Third Supplemental Indenture, dated as of December 10, 2024, between CVS Health Corporation and The Bank of New York Mellon Trust Company, N.A. 4.4 Form of the Series A Junior Subordinated Notes (included in Exhibit 4.2 hereto). 4.5 Form of the Series B Junior Subordinated Notes (included in Exhibit 4.3 hereto). 5.1 Opinion of Wachtell, Lipton, Rosen & Katz 23.1 Consent of Wachtell, Lipton, Rosen & Katz (included in Exhibit 5.1). 104 Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CVS HEALTH CORPORATION Date: December 10, 2024 By: /s/ Thomas F. Cowhey Thomas F. Cowhey Executive Vice President and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR